| |
|
BETHESDA,
MD, (October 5, 2004) -- Candela Corporation (NASDAQ: CLZR),
a pioneer in the development and commercialization of aesthetic laser
systems, and Chindex International, Inc. (NASDAQ: CHDX), a leading
independent American provider of western healthcare products and services
in the People's Republic of China, jointly announced today an exclusive,
multi-year distribution agreement for the People's Republic of China,
including Hong Kong.
Under
the terms of the agreement, Chindex will market and distribute the
extensive Candela product line of aesthetic laser systems to dermatologists,
plastic surgeons, family practitioners, OB/GYNs, and general and vascular
surgeons throughout the healthcare industry in China . The Candela
products offer technologies for hair removal, wrinkle reduction, the
treatment of vascular and pigmented lesions, tattoos, acne, and atrophic
acne scars.
Chindex
President and CEO, Roberta Lipson, said that the emerging market for
aesthetic laser treatment in China is very significant. "In
the quickly growing economies of the urban cities in China,
the business of aesthetic health technologies is growing rapidly.
This is a technology which will command a broad and expanding
market in China ."
"We
believe Candela and Chindex will make a great team." Lipson said.
"We have already had a Candela Laser Clinic and Training Center
at our company's Beijing United Family Hospital for the past year.
The Center treats patients of the hospital, as well as trains
new and potential customers of Candela in China . Both patient and
market reaction have been very impressive. This highlights the
synergistic qualities between the products and healthcare services
divisions of Chindex, as well as our strong basis for confidence in
future laser sales."
Candela
President and CEO, Gerard E. Puorro, said: "Strategically, Chindex
is the right partner at the right time. They possess strong
distribution skills in China
in both capital equipment and cosmetics. Together we look forward
to expanding the Chinese market for laser cosmetics and aesthetics."
About
Chindex International, Inc.
Chindex
is an American company operating in several healthcare sectors of
the Chinese marketplace, including Hong Kong . It provides representative
and distribution services to a number of major multinational companies
including Siemens AG (ultrasound systems), and Guidant (interventional
cardiology products including stents, balloon catheters and guide
wires). Its distribution channels to the retail pharmacy industry
in China have been developed through a relationship with a major multinational
cosmetics manufacturer. It also provides healthcare services
through the operations of its private hospital corporation in China
. With twent-(three years of experience, over 700 employees, and operations
in the United States , China and Hong Kong , the Company's strategy
is to expand its cross-cultural reach by providing leading edge technologies,
quality products and services to Greater China's professional communities.
Further company information may be found at the Company's websites,
www.chindex.com and www.umitedfamilyhospitals.com
.
About
Candela :
Candela
Corporation, an ISO-9001 certified company, develops, manufactures,
and distributes innovative clinical solutions that enable physicians,
surgeons, and personal care practitioners to treat selected cosmetic
and medical conditions using lasers, aesthetic laser systems, and
other advanced technologies. Founded near Boston in 1970, the
company markets and services its products in over 64 countries from
offices in the United States , Europe , Japan and other Asian locations.
Candela established the aesthetic laser market 15 years ago,
and currently has an installed base of over 7,000 lasers worldwide.
Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran).
Visit Candela on the Web at http://www.candelalaser.com
.
The
statements in this press release that relate to future plans, events
or performance are forward(looking statements that involve risks and
uncertainties, including risks associated with uncertainties pertaining
to the Company's (i) successful marketing and distribution of new
products, including aesthetic laser systems, (ii) performance goals,
including successful conclusion of efforts to secure government-backed
financing, (iii) future events and earnings, including revenues from
the Company's developmental businesses such as healthcare services,
(iv) markets, including growth in demand in China for the Company's
products and services, and (v) proposed new operations, including
expansion of its healthcare services business. Actual results,
events and performance may differ materially. Readers are cautioned
not to place undue reliance on these forwar-(looking statements, which
speak only as of the date hereof. The Company undertakes no
obligation to release publicly the result of any revisions to these
forward-looking statements that may be made to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated
events.
#
# #
|
